Table 3.
Odds of Using Female Sterilization or Reversible Prescription Contraception Compared With Using Neither
| Medical Condition | Aged 15–34 Years* | Aged 35–44 Years* | ||
|---|---|---|---|---|
| Female Sterilization vs Neither | Reversible Prescription Contraceptive† vs Neither | Female Sterilization vs Neither | Reversible Prescription Contraceptive† vs Neither | |
| Any medical condition‡ | 4.88 (4.46–5.33) | 1.13 (1.08–1.18) | 1.16 (1.11–1.21) | 0.84 (0.82–0.87) |
| Hypertension | 7.29 (6.55–8.10) | 1.23 (1.16–1.31) | 1.17 (1.11–1.22) | 0.89 (0.86–0.92) |
| Diabetes | 4.09 (3.43–4.87) | 1.10 (1.01–1.19) | 1.05 (0.97–1.14) | 0.72 (0.68–0.76) |
| Epilepsy | 1.43 (1.04–1.97) | 0.88 (0.80–0.97) | 0.99 (0.79–1.24) | 0.60 (0.50–0.71) |
| Breast cancer | NR§ | 0.88 (0.59–1.33) | 0.77 (0.63–0.94) | 0.45 (0.38–0.52) |
| Stroke | 4.57 (3.17–6.60) | 0.87 (0.72–1.06) | 1.12 (0.91–1.36) | 0.60 (0.51–0.71) |
| Bariatric surgery within 2 y | NR§ | 1.50 (1.20–1.89) | 1.30 (1.07–1.58) | 0.97 (0.85–1.12) |
| Ischemic heart disease | NR§ | 1.06 (0.77–1.46) | 0.88 (0.71–1.10) | 0.52 (0.44–0.62) |
| Lupus | NR§ | 0.96 (0.78–1.18) | 0.78 (0.60–1.02) | 0.72 (0.61–0.85) |
| Thrombophilia | 8.75 (5.97–12.82) | 0.82 (0.62–1.08) | 1.60 (1.22–2.10) | 0.61 (0.48–0.79) |
Data are odds ratio (95% confidence interval).
Bold indicates significant results (P<.01).
Odds ratio represents the odds of using female sterilization or a reversible prescription method (intrauterine device [IUD], implant, injectable, pill, patch, or ring) compared with neither among those with the selected medical condition compared with those without any of the 21 medical conditions.
Includes IUD, implant, injectable, pill, patch, or ring.
Any of the 21 medical conditions identified by the U.S. Medical Eligibility Criteria for Contraceptive Use9 as placing women at increased risk for adverse events if they experience an unintended pregnancy (bariatric surgery within 2 years, breast cancer, diabetes, epilepsy, hypertension, ischemic heart disease, lupus, stroke, thrombophilia, endometrial cancer, ovarian cancer, human immunodeficiency virus, trophoblastic disease, liver cancer, peripartum cardiomyopathy, schistosomiasis, cirrhosis, sickle cell disease, transplant within 2 years, tuberculosis, and valvular heart disease).
Not reported because of small numbers (less than 30).